|
1
|
Ferron M and Lacombe J: Regulation of energy metabolism by the skeleton: Osteocalcin and beyond. Arch Biochem Biophys. 561:137–146. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fishbein GA and Fishbein MC: Arteriosclerosis: Rethinking the current classification. Arch Pathol Lab Med. 133:1309–1316. 2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW and Kroon AA: Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis. Vasc Health Risk Manag. 5:185–197. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shobeiri N, Adams MA and Holden RM: Vascular calcification in animal models of CKD: A review. Am J Nephrol. 31:471–481. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
World Health Organization: Cardiovascular Diseases. https://www.who.int/health-topics/cardiovascular-diseases/#tab=tab_1. Accessed December 2, 2020.
|
|
6
|
Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R and Taubert K: Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical applications. Circulation. 94:1175–1192. 1996.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zoch ML, Clemens TL and Riddle RC: New insights into the biology of osteocalcin. Bone. 82:42–49. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, et al: Endocrine regulation of energy metabolism by the skeleton. Cell. 130:456–469. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sheng L, Cao W, Cha B, Chen Z, Wang F and Liu J: Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol. 12(22)2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tacey A, Qaradakhi T, Brennan-Speranza T, Hayes A, Zulli A and Levinger I: Potential role for osteocalcin in the development of atherosclerosis and blood vessel disease. Nutrients. 10(E1426)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Millar SA, Patel H, Anderson SI, England TJ and O'Sullivan SE: Osteocalcin, vascular calcification, and atherosclerosis: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 8(183)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lund SA, Giachelli CM and Scatena M: The role of osteopontin in inflammatory processes. J Cell Commun Signal. 3:311–322. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lok ZSY and Lyle AN: Osteopontin in vascular disease. Arterioscler Thromb Vasc Biol. 39:613–622. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Moe SM, Duan D, Doehle BP, O'Neill KD and Chen NX: Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int. 63:1003–1011. 2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL and Shanahan CM: Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol. 23:489–494. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li Y, Wang W, Chao Y, Zhang F and Wang C: CTRP13 attenuates vascular calcification by regulating Runx2. FASEB J. 33:9627–9637. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhu L, Zhang N, Yan R, Yang W, Cong G, Yan N, Ma W, Hou J, Yang L and Jia S: Hyperhomocysteinemia induces vascular calcification by activating the transcription factor RUNX2 via Krüppel-like factor 4 up-regulation in mice. J Biol Chem. 294:19465–19474. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Rasmussen R: Quantification on the Light Cycler. In: Rapid Cycle Real-Time PCR. Meuer S, Wittwer C and Nakagawara KI (eds). Springer, Heidelberg, pp21-34 2001.
|
|
20
|
Mizokami A, Kawakubo-Yasukochi T and Hirata M: Osteocalcin and its endocrine functions. Biochem Pharmacol. 132:1–8. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li J, Zhang H, Yang C, Li Y and Dai Z: An overview of osteocalcin progress. J Bone Miner Metab. 34:367–379. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kord-Varkaneh H, Djafarian K, Khorshidi M and Shab-Bidar S: Association between serum osteocalcin and body mass index: A systematic review and meta-analysis. Endocrine. 58:24–32. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Pal SN, Rush C, Parr A, Van Campenhout A and Golledge J: Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. Atherosclerosis. 210:88–93. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yuen CY, Wong SL, Lau CW, Tsang SY, Xu A, Zhu Z, Ng CF, Yao X, Kong SK, Lee HK, et al: From skeleton to cytoskeleton: Osteocalcin transforms vascular fibroblasts to myofibroblasts via angiotensin II and Toll-like receptor 4. Circ Res. 111:e55–e66. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ramirez-Sandoval JC, Casanova I, Villar A, Gomez FE, Cruz C and Correa-Rotter R: Biomarkers associated with vascular calcification in peritoneal dialysis. Perit Dial Int. 36:262–268. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Schinzari F, Tesauro M, Bertoli A, Valentini A, Veneziani A, Campia U and Cardillo C: Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: Influence of oral hypoglycemic agents. Am J Physiol Endocrinol Metab. 317:E658–E666. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Icer MA and Gezmen-Karadag M: The multiple functions and mechanisms of osteopontin. Clin Biochem. 59:17–24. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Speer MY, McKee MD, Guldberg RE, Liaw L, Yang HY, Tung E, Karsenty G and Giachelli CM: Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med. 196:1047–1055. 2002.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Scatena M, Liaw L and Giachelli CM: Osteopontin: A multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol. 27:2302–2309. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Golledge J, Muller J, Shephard N, Clancy P, Smallwood L, Moran C, Dear AE, Palmer LJ and Norman PE: Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 27:655–660. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Berezin AE and Kremzer AA: Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. Atherosclerosis. 229:475–481. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Cho HJ, Cho HJ and Kim HS: Osteopontin: A multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep. 11:206–213. 2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lino M, Wan MH, Rocca AS, Ngai D, Shobeiri N, Hou G, Ge C, Franceschi RT and Bendeck MP: Diabetic vascular calcification mediated by the collagen receptor discoidin domain receptor 1 via the phosphoinositide 3-kinase/Akt/Runt-related transcription factor 2 signaling axis. Arterioscler Thromb Vasc Biol. 38:1878–1889. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tanaka T, Sato H, Doi H, Yoshida CA, Shimizu T, Matsui H, Yamazaki M, Akiyama H, Kawai-Kowase K, Iso T, et al: Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells. Mol Cell Biol. 28:1147–1160. 2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Al-Huseini I, Ashida N and Kimura T: Deletion of IκB-Kinase β in smooth muscle cells induces vascular calcification through β-catenin-Runt-related transcription factor 2 signaling. J Am Heart Assoc. 7(e007405)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Deng L, Huang L, Sun Y, Heath JM, Wu H and Chen Y: Inhibition of FOXO1/3 promotes vascular calcification. Arterioscler Thromb Vasc Biol. 35:175–183. 2015.PubMed/NCBI View Article : Google Scholar
|
